November 10, 2025 — Leads & Copy — Vistagen (Nasdaq: VTGN) will host a conference call and webcast on Thursday, November 13, 2025, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report results for its fiscal year 2026 second quarter ended September 30, 2025, and provide a corporate update.
The live webcast can be accessed under “Events” in the Investors section of the Company’s website. Participants should click on the webcast link and follow the prompts for registration and access at least 10 minutes before the call. The webcast will be archived on Vistagen’s website shortly after the call and will be available for at least 90 days.
Participants interested in joining the call via dial-in can use the following details:
- Conference ID: 6458570
- Participant Toll-Free Dial-In Number: 1(646) 307-1952
- Participant International Dial-In Number: 1(646) 307-1963
Vistagen (Nasdaq: VTGN), headquartered in South San Francisco, CA, is a late clinical-stage biopharmaceutical company. It leverages a deep understanding of nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines.
Pherines selectively bind as agonists on peripheral receptors on human nasal chemosensory neurons and are designed to rapidly trigger olfactory bulb-to-brain neurocircuits believed to regulate brain areas involved in behavior and autonomic nervous system activity. They are designed to achieve therapeutic benefits without requiring absorption into the blood or uptake into the brain, giving them the potential to be a safer alternative to other pharmacological options if successfully developed and approved.
Vistagen is focused on developing transformative treatment options to improve the lives of individuals underserved by the current standard of care for multiple highly prevalent indications, including social anxiety disorder, major depressive disorder, vasomotor symptoms (hot flashes) associated with menopause and premenstrual dysphoric disorder.
Connect at www.Vistagen.com
Source: Vistagen
